CLINICAL_TRIALS
trial_result
· 2014-08-08
Clinical Trial Update: NP2 Enkephalin For Treatment of Intractable Cancer Pain [Phase 2]
Summary
Phase 2 clinical trial evaluating NP2 Enkephalin for intractable cancer pain has completed. The study targeted patients with neoplasms.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Diamyd Inc | Conditions: Intractable Pain, Neoplasms | Phase 2 | Status: COMPLETED